Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.14), $0.10 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $41.14 million versus the consensus estimate of $67.36 million.

GUIDANCE:

Ironwood Pharma sees FY2025 revenue of $260-290 million, versus the consensus of $286.8 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.